The largest database of trusted experimental protocols

Quantikine human immunoassay kit

Manufactured by R&D Systems
Sourced in United States

The Quantikine Human Immunoassay kits are in vitro diagnostic products designed to quantitatively measure specific human proteins in cell culture supernates, serum, plasma, and other biological fluids. The kits utilize enzyme-linked immunosorbent assay (ELISA) technology.

Automatically generated - may contain errors

13 protocols using quantikine human immunoassay kit

1

Growth Factor Quantification in Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
During the cell culture period, the spent medium was collected for the analysis of growth factors; transforming growth factor (TGF)-β and interleukin (IL)-1β were chosen for the analyses. Active TGF-β and IL-1β concentrations were determined using enzyme-linked immunosorbent assay (ELISA) in duplicate aliquots of all samples with the Quantikine Human Immunoassay kits (R&D Systems, Minneapolis, Minnesota).
+ Open protocol
+ Expand
2

Quantification of PGE2 and NO

Check if the same lab product or an alternative is used in the 5 most similar protocols
The amount of PGE2 released into the medium was quantified by ELISA using the Quantikine Human Immunoassay kits (R&D Systems, Minneapolis, MN, USA) according to manufacturer’s instructions. The production of NO was measured by Griess reaction using the NO Assay Kit (Thermo Fisher Scientific, Rockford, IL, USA) according to manufacturer’s instructions.
+ Open protocol
+ Expand
3

Quantifying Angiogenic Factors in Co-cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
The concentration of VEGF-A, TGF-β and PDGF-BB released in single cultures and in co-culture supernatants were determined by ELISA using Quantikine Human Immunoassay kits (all by R&D Systems, Minneapolis, MN, USA), according to the manufacturer’s protocol. After 48 hrs of co-culture and tube formation, media samples were collected and tested.
+ Open protocol
+ Expand
4

Activation and Cytokine Release of PRP

Check if the same lab product or an alternative is used in the 5 most similar protocols
PCP obtained from different first-spin conditions and P-PRP obtained using different second-spin conditions were activated with 10% CaCl2 (final concentration, 22.8 mM). Subsequently, the formulations were incubated at 37°C in a humidified atmosphere with 5% CO2 for 2 h. At the end of the incubation period, the formulations were centrifuged at 2,800×15 and the supernatant was collected and stored at −80°C until analysis. The supernatant was assayed for IL-1β, tumor necrosis factor (TNF)-α, platelet-derived growth factor (PDGF)-AB and transforming growth factor (TGF)-β1 with Quantikine Human Immunoassay kits (R&D Systems, Minneapolis, MN, USA) according to the manufacturer's protocol.
+ Open protocol
+ Expand
5

Quantification of Growth Factors and Cytokines

Check if the same lab product or an alternative is used in the 5 most similar protocols
PDGF-AB, TGF-β1, VEGF, IL-1β, and TNF-α concentrations of whole blood, L-PRP, and P-PRP were quantified by enzyme-linked immunosorbent assay (ELISA) [30 (link)]. In brief, whole blood, L-PRP, and P-PRP were incubated with 10 % CaCl2 (final concentration 22.8 mM) at 37 °C for 7 days. At the end of the incubation period, the formulations were spun at 2800g for 15 min, and the supernatants were collected and assayed for growth factors and pro-inflammatory cytokine concentrations using the Quantikine Human Immunoassay kits (R&D Systems, Minneapolis, MN, USA) according to manufacturer’s instructions.
+ Open protocol
+ Expand
6

Quantification of Growth Factors in Activated PRP

Check if the same lab product or an alternative is used in the 5 most similar protocols
ELISA was performed to quantify PDGF-AB and TGF-β1 concentrations in activated PRP samples as described elsewhere [14 (link)]. Briefly, PRP samples were incubated in 10% calcium chloride (final concentration 22.8 mM) for seven days at 37°C in a humidified atmosphere with 5% CO2. Then, the formulations were spun at 2800 g for 15 minutes to collect the supernatant. PDGF-AB and TGF-β1 concentrations in the supernatant were determined using the Quantikine Human Immunoassay kits (R&D Systems, Minneapolis, MN, USA) according to manufacturer’s instructions.
+ Open protocol
+ Expand
7

Serum Adhesion Molecules and Inflammatory Analytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum adhesion molecules (soluble E-selectin [sE-Selectin], soluble P-selectin [sP-Selectin], soluble intercellular adhesion molecule-1 [sICAM-1], and soluble vascular cell adhesion molecule-1 [sVCAM-1]), as well as inflammatory analytes (interleukin [IL]-6, IL-1β, tumor necrosis factor-α), were measured using a Quantikine human immunoassay kits (R&D Systems, Minneapolis, MN, USA). All these inter-assay CVs ranged between 4 and 8%.
+ Open protocol
+ Expand
8

Quantification of Growth Factors and Cytokines in Platelet-Rich Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
The concentrations of PDGF-AB, TGF-β1, IL-1β and TNF-α in the whole blood, L-PRP and P-PRP samples were quantified according to the protocols described previously (14 (link)). In brief, the whole blood, L-PRP and P-PRP samples were incubated with 10% CaCl2 (final concentration, 22.8 mM) at 37°C in a humidified atmosphere containing 5% CO2 for 7 days. At the end of the incubation period, the supernatants were collected, and the concentrations of growth factors and pro-inflammatory cytokines were determined using an enzyme-linked immunosorbent assay (ELISA) with the Quantikine Human Immunoassay kits (R&D Systems, Inc., Minneapolis, MN, USA) according to manufacturer's protocol.
+ Open protocol
+ Expand
9

Serum Biomarker Profiling in Trastuzumab Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
We collected serum samples at four time points: before treatment (baseline), immediately before the second and fourth trastuzumab administrations, and after confirmation of progressive disease (PD). Serum HER2 levels were measured by a chemiluminescence immunoassay (Siemens Healthcare Diagnostic, Tokyo, Japan). All other serum markers were measured by enzyme-linked immunosorbent assay (ELISA): EGF, TGF-a, and NRG1 levels were measured with DuoSet ELISA Development Systems kits (R&D Systems, Minneapolis, MN, USA), and HGF, IGF1, and tissue inhibitor of metalloproteinase 1 were measured with Quantikine human immunoassay kits (R&D Systems). All assays were performed in duplicate. The lower limits of detection were 3.91 pg/ml for EGF, 7.81 pg/ml for TGF-a, and 62.5 pg/ml for NRG1.
+ Open protocol
+ Expand
10

Adiponectin Levels in Hemorrhagic Shock

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human subject study was approved by the University of Texas Health Science Center at Houston (UTHSC-H) Committee for the Protection of Human Subjects as waiver of informed consent. Severely injured patients in hemorrhagic shock with a systolic blood pressure <90 mmHg and/or a base deficit of >5 meq/ml who received at least one unit of blood after Emergency Department (ED) arrival but prior to Intensive Care Unit (ICU) admission were eligible for the study. Subject demographics, laboratory values and outcomes were obtained from patient records. Blood samples were obtained upon admission to the ED (referenced as pre-resuscitation) and subsequently upon arrival to the ICU (referenced as post-resuscitation) at Memorial Hermann Hospital, Houston, TX, a Level I trauma center. Blood samples were also obtained from healthy subjects following obtainment of consent. After collection, blood samples were centrifuged and plasma aliquots prepared and stored at -80°C for subsequent analysis. Levels of total human adiponectin in plasma were measured using Quantikine Human Immunoassay kit from R&D Systems (Minneapolis, MN).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!